CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The UEPHA-MS project focuses on multiple sclerosis, aiming to enhance understanding of treatment responses through pharmacogenomics and biomarker research. It seeks to train young scientists in these areas to improve therapeutic strategies and personalized medicine approaches for MS.
Multiple sclerosis (MS) is a chronic inflammatory, disabling disease of the central nervous system.
Recent studies suggest that over the last 50 years a disproportional increase in incidence of MS in women has taken place.
The lifetime costs of MS exceed 1.5 million € per case in the UK, and are likely to be similar in other European countries.
There is no definitive cure for MS.
Immunomodulatory therapies, such as interferon-β (IFN-β) and glatiramer acetate (GA), are only partially effective. H…
UNIVERSIDAD DEL PAIS VASCO/ EUSKAL HERRIKO UNIBERTSITATEA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
